UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056026 |
|---|---|
| Receipt number | R000064027 |
| Scientific Title | Multiple logistic analysis relating about elderly respiratory disease (retrospective study) |
| Date of disclosure of the study information | 2024/12/01 |
| Last modified on | 2024/11/02 12:49:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analysis of multiple factors relating about elderly respiratory disease (retrospective study)
Acronym
Analysis of multiple factors relating about elderly respiratory disease
Scientific Title
Multiple logistic analysis relating about elderly respiratory disease (retrospective study)
Scientific Title:Acronym
Multiple logistic analysis relating about elderly respiratory disease
Region
| Japan |
Condition
Condition
elderly respiratory diseases
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate multiple factors relating elderly respiratory diseases
Basic objectives2
Others
Basic objectives -Others
About respiratory elderly cases admitted in our hospital before, evaluate multiple factors using multiple logistic analysis
Trial characteristics_1
Confirmatory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
mortality after 30-days of admission length, or complications related its diagnosis
Key secondary outcomes
length of admission days, content of treatment, severity of diseases
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 70 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Respiratory disease cases more than 70
Key exclusion criteria
none
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Yasuyuki |
| Middle name | |
| Last name | Taooka |
Organization
Medical corporation JR Hiroshima Hospital
Division name
Department of respiratory disease
Zip code
732-0057
Address
3-1-36, Futabanosato, HIgashi-ku, Hiroshima
TEL
082-262-1171
taooka-alg@umin.ac.jp
Public contact
Name of contact person
| 1st name | Yasuyuki |
| Middle name | |
| Last name | Taooka |
Organization
Medical corporation JR Hiroshima Hospital
Division name
Department of respiratory disease
Zip code
732-0057
Address
3-1-36, Futabanosato, HIgashi-ku, Hiroshima
TEL
082-262-1171
Homepage URL
http://www.jrhh.or.jp/.
taooka-alg@umin.ac.jp
Sponsor or person
Institute
Medical corporation JR Hiroshima Hospital
Institute
Department
Personal name
Yasuyuki Taooka
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
none
Other related organizations
Co-sponsor
none
Name of secondary funder(s)
none
IRB Contact (For public release)
Organization
Medical corporation Hiroshima JR Hospital
Address
3-1-36, Futabanosato, HIgashi-ku, Hiroshima
Tel
082-262-1171
taooka-alg@umin.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 11 | Month | 01 | Day |
Date of IRB
| 2024 | Year | 07 | Month | 05 | Day |
Anticipated trial start date
| 2024 | Year | 12 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 11 | Month | 30 | Day |
Date of closure to data entry
| 2025 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
| 2025 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2025 | Year | 12 | Month | 31 | Day |
Other
Other related information
We will analyze the clinical information from medical records which admitted in our hospital before.
Management information
Registered date
| 2024 | Year | 11 | Month | 02 | Day |
Last modified on
| 2024 | Year | 11 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064027
